Dr. Wu Skincare Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 01, 2022
Share
Dr. Wu Skincare Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 224.99 million compared to TWD 331.45 million a year ago. Net income was TWD 81.73 million compared to TWD 104.15 million a year ago. Basic earnings per share from continuing operations was TWD 1.81 compared to TWD 2.31 a year ago. Diluted earnings per share from continuing operations was TWD 1.81 compared to TWD 2.31 a year ago.
For the nine months, sales was TWD 648.21 million compared to TWD 804.27 million a year ago. Net income was TWD 245.18 million compared to TWD 213.29 million a year ago. Basic earnings per share from continuing operations was TWD 5.44 compared to TWD 4.73 a year ago. Diluted earnings per share from continuing operations was TWD 5.44 compared to TWD 4.73 a year ago.
DR.Wu Skincare Co Ltd is a Taiwan-based company mainly engaged in the research and development and sales of cosmetics and skin care products. The main products include hyaluronic acid moisturizing series, mandelic acid skin rejuvenating series, super anti-aging repair series, squalane plant extract repair series, translucent whitening series, laboratory essence series, super retinol rejuvenating series, capsule mask series, all-round sunscreen series, mineral flawless foundation series, beauty health food series, reâdermx, and others. The Company mainly distributes products in Taiwan.